antiapoptotic signaling pathway large-cell lymphoma activates the phosphatidylinositol 3-kinase / Akt anaplastic lymphoma kinase associated with anaplastic − Nucleophosmin

http://bloodjournal.hematologylibrary.org/content/96/13/4319.full.html Updated information and services can be found at: (1930 articles) Signal Transduction • (4217 articles) Neoplasia • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  R. Siebert,et al.  Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. , 2000, Blood.

[2]  E. Campo,et al.  A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. , 2000, Cancer research.

[3]  John Calvin Reed,et al.  p21-Activated Kinase 1 Phosphorylates the Death Agonist Bad and Protects Cells from Apoptosis , 2000, Molecular and Cellular Biology.

[4]  E. Campo,et al.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. , 1999, Blood.

[5]  A. Rosenwald,et al.  TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. , 1999, Blood.

[6]  Asim Khwaja,et al.  Apoptosis: Akt is more than just a Bad kinase , 1999, Nature.

[7]  E. Kandel,et al.  Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria , 1999, Molecular and Cellular Biology.

[8]  A. Rosenwald,et al.  t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. , 1999, Blood.

[9]  J. Downward,et al.  Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor , 1999, Molecular and Cellular Biology.

[10]  K. Pulford,et al.  A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. , 1999, Blood.

[11]  M. Welham,et al.  Dissociation of Apoptosis from Proliferation, Protein Kinase B Activation, and BAD Phosphorylation in Interleukin-3-mediated Phosphoinositide 3-Kinase Signaling* , 1999, The Journal of Biological Chemistry.

[12]  M. Waterfield,et al.  Signalling through phosphoinositide 3-kinases: the lipids take centre stage. , 1999, Current opinion in cell biology.

[13]  K. Nishida,et al.  Anti-apoptotic function of Rac in hematopoietic cells , 1999, Oncogene.

[14]  S. Morris,et al.  Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity , 1998, Molecular and Cellular Biology.

[15]  Jon C. Aster,et al.  Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow , 1998 .

[16]  R. Kolesnick,et al.  BAD Enables Ceramide to Signal Apoptosis via Ras and Raf-1* , 1998, The Journal of Biological Chemistry.

[17]  A. Hagemeijer,et al.  The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. , 1998, Blood.

[18]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[19]  N. Hay,et al.  Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line , 1998, Molecular and Cellular Biology.

[20]  D. Cantrell,et al.  Protection of CD95‐mediated apoptosis by activation of phosphatidylinositide 3‐kinase and protein kinase B , 1998, European journal of immunology.

[21]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[22]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[23]  B. Calabretta,et al.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway , 1997, The EMBO journal.

[24]  F. Behm,et al.  Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. , 1997, Blood.

[25]  E. Ruaro,et al.  Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts , 1997, Molecular and cellular biology.

[26]  K. Kolibaba,et al.  Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed Myeloid Cells* , 1997, The Journal of Biological Chemistry.

[27]  L. Varticovski,et al.  Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase , 1997, Oncogene.

[28]  C. Naeve,et al.  ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) , 1997, Oncogene.

[29]  K. Pulford,et al.  Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.

[30]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[31]  T. Hunter.  Oncoprotein Networks , 1997, Cell.

[32]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[33]  T. Arakawa,et al.  Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system , 1997, Oncogene.

[34]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[35]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[36]  S. Shoelson,et al.  Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor , 1996, Cell.

[37]  W. Langdon,et al.  The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. , 1996, Oncogene.

[38]  H. Satoh,et al.  Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Warne,et al.  Phosphatidylinositol 3' kinase: one of the effectors of Ras. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[40]  R. Salgia,et al.  The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. , 1996, Oncogene.

[41]  S. Arkins,et al.  Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. , 1996, Journal of immunology.

[42]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[43]  Seamus J. Martin,et al.  Regulation of the Fas Apoptotic Cell Death Pathway by Abl (*) , 1995, The Journal of Biological Chemistry.

[44]  B. Burgering,et al.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction , 1995, Nature.

[45]  G. Zon,et al.  Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. , 1995, Blood.

[46]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[47]  Y. Yazaki,et al.  Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo. , 1994, Oncogene.

[48]  H. Satoh,et al.  Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. , 1994, Oncogene.

[49]  M. Kadin.  Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[51]  Y. Nonomura,et al.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. , 1993, The Journal of biological chemistry.

[52]  J. Testa,et al.  The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. , 1993, Oncogene.

[53]  A. Cherniack,et al.  Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. , 1993, Science.

[54]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[55]  O. Witte,et al.  Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. , 1992, Science.

[56]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[57]  A. Ullrich,et al.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases , 1991, Cell.

[58]  V. Fried,et al.  cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.

[59]  H. Stein,et al.  The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[60]  G. Daley,et al.  Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants , 1991, Molecular and cellular biology.

[61]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[62]  L. Cantley,et al.  Phosphatidylinositol 3 kinase is activated by insulin , 1990 .

[63]  R. Warnke,et al.  CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 , 1990, British journal of haematology.

[64]  M. Olson,et al.  Interaction of nucleolar phosphoprotein B23 with nucleic acids. , 1989, Biochemistry.

[65]  R. Warnke,et al.  Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. , 1989, Blood.

[66]  C. Lehner,et al.  Major nucleolar proteins shuttle between nucleus and cytoplasm , 1989, Cell.

[67]  Qing-Rong Liu,et al.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.

[68]  J. Hartley,et al.  Thymic lymphoma induction by the AKT8 murine retrovirus , 1988, The Journal of experimental medicine.

[69]  O. Witte,et al.  In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Hartley,et al.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Jain,et al.  PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl. , 1996, Blood.

[72]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.